Sort
39,280 grants matching “leukemia”
Is Chromosome Therapy Possible for Down Syndrome and Other Karyotypic Imbalances?
$325,710Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · GM
Nanopatterned Surfaces to Control Cell Fate
$325,671Kevin E Healy · University Of California Berkeley · R01 · FY2011 · GM
Cellular Imaging and Molecular Pathology
$325,660Christopher H Contag · Stanford University · P01 · FY2008 · CA
Identification of Methylated Genes in Chronic Lymphocytic Leukemia
$325,653Christoph Plass · Ohio State University · P01 · FY2007 · CA
ROCK II-mediated regulation of centrosome duplication / centrosome amplification
$325,650Kenji Fukasawa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · GM
Generalizable biomedical informatics strategies for predictive modeling of treatment response
$325,640Antonina Mitrofanova · Rbhs-School/ Health Related Professions · R01 · FY2021 · LM
Understanding T Cell Rapamycin Resistance
$325,640Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Generalizable biomedical informatics strategies for predictive modeling of treatment response
$325,640Antonina Mitrofanova · Rutgers Biomedical And Health Sciences · R01 · FY2022 · LM
Generalizable biomedical informatics strategies for predictive modeling of treatment response
$325,640Antonina Mitrofanova · Rutgers Biomedical And Health Sciences · R01 · FY2023 · LM
Targeting BCL6 in tyrosine kinase-driven leukemia
$325,602Markus Mãschen · University Of California, San Francisco · R01 · FY2013 · CA
A PHASE 1 Study of HuD10 IN CLL/SLL PATIENTS
$325,561Ohio State University · R21 · FY2001 · CA
RhoH GTPase in Hematopoiesis and Cancer
$325,549David A Williams · Boston Children'S Hospital · R01 · FY2012 · CA
Crenolanib and ponatinib for the treatment of FLT3 mutant AML
$325,515Neil P Shah · University Of California, San Francisco · R01 · FY2013 · CA
FLT3 as a Target for Drug Discovery to Treat Leukemia
$325,515Johns Hopkins University · U01 · FY2001 · CA
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
$325,500David Steven Libich · University Of Texas Hlth Science Center · R01 · FY2024 · GM
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
$325,500David Steven Libich · University Of Texas Hlth Science Center · R01 · FY2025 · GM
Genomics of Teatment-Related AML
$325,498Daniel C Link · Washington University · P01 · FY2014 · CA
Effect of APOBEC3G on retroviruses and retrotransposons
$325,465Bryan R. Cullen · Duke University · R01 · FY2009 · AI
Effect of APOBEC3G on retroviruses and retrotransposons
$325,465Bryan R. Cullen · Duke University · R01 · FY2008 · AI
Neuronal Development, Injury and Regeneration in Retina
$325,452Peter F Hitchcock · University Of Michigan At Ann Arbor · R01 · FY2008 · EY
Administrative Core
$325,419Charles G. Mullighan · St. Jude Children'S Research Hospital · U54 · FY2019 · CA
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
$325,412Jing Chen · Emory University · R01 · FY2016 · CA
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
$325,412Jing Chen · Emory University · R01 · FY2017 · CA
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
$325,412Jing Chen · Emory University · R01 · FY2018 · CA
Enhancing Lympho-Hematopoietic Recovery after Allogeneic UCBT
$325,393John E Wagner · University Of Minnesota · P01 · FY2015 · CA